Zachary Roberts

Chief Executive Officer at ALLOGENE THERAPEUTICS, INC.

Net worth: 362 938 $ as of 2026-07-30

48 year

Health Technology

Consumer Services

Profile

Zachary Roberts is currently President, Chief Executive Officer & Director at Allogene Therapeutics, Inc., starting in 2026.
Formerly, Dr. Roberts was Chief Medical Officer at Instil Bio, Inc. from 2020 to 2022, Vice President-Clinical Development at Kite Pharma, Inc. from 2018 to 2019, and Director-Clinical Medical Research at Amgen, Inc. in 2015.
Education includes undergraduate studies at the University of Maryland and a doctorate from the University of Maryland School of Medicine.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ALLOGENE THERAPEUTICS, INC. 0.06%	2026-06-30	193,052 ( 0.06% )	362 938 $	2026-07-30

Zachary Roberts active positions

Companies	Position	Start
ALLOGENE THERAPEUTICS, INC.	Chief Executive Officer	2026-06-30

All active positions of Zachary Roberts

Former positions of Zachary Roberts

Companies	Position	End
INSTIL BIO, INC.	Chief Tech/Sci/R&D Officer	2022-11-10
KITE PHARMA INC	Chief Tech/Sci/R&D Officer	2019-04-30
AMGEN INC.	Chief Tech/Sci/R&D Officer	2015-06-30

See the detail of Zachary Roberts's experience

Training of Zachary Roberts

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Zachary Roberts's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
University of Maryland University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Maryland School of Medicine University of Maryland School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kite Pharma, Inc. Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products	Health Technology
Allogene Therapeutics, Inc. Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology	Health Technology
Instil Bio, Inc. Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer	Health Technology